CD8A and non-small cell lung carcinoma: CD8-positive TILs are known to increase after neoadjuvant chemotherapy in resected NSCLC specimens, suggesting that cytotoxic chemotherapy promotes antitumor immunity through T- and B-cell recruitment in the immune microenvironment (20).